EREBRAL ischemia-reperfusion injury is characterized by a profound transient reduction in cerebral blood flow (CBF) that is followed by reperfusion. During the reperfusion period, ischemic edema and physiological abnormalities of neuroelectrical function may develop progressively. Clinically, ischemic edema formation is a major factor contributing to poor outcome after a transient cerebral ischemic insult. One approach to reducing the clinical effects of cerebral ischemia-reperfusion injury is to develop therapies that protect the neuronal cells from its secondary metabolic effects.
Materials and Methods
In these studies, we carefully adhered to the animal welfare guidelines set forth in the Guide for the Care and Use of Laboratory Animals, U.S. Department of Health and Human Services, Publication No. 1985 .
Preparation of Animals
Forebrain ischemia was induced in Mongolian gerbils weighing from 47 g to 80 g. The animals were anesthetized by means of an intraperitoneal dose of combined anesthetic medications (87 mg/kg ketamine hydrochloride and 13 mg/kg xylazine). In each gerbil, both common carotid arteries were isolated and dental floss was looped around each artery. The end of a double-lumen vinyl tube (2.5 cm long, 1.1 mm inner diameter, 2.5 mm outer diameter) was placed next to each carotid artery with one end exiting the gerbil just posterior and inferior to the ear. The tube had a double lumen to avoid twisting of, or adhesion between, the lengths of floss. Two double-lumen tubes were used per animal. The tubing was held in place with cyanoacrylate adhesive applied to the skin of the exit wound. Each end of the dental floss was passed through a separate tube lumen to form a snare by which ischemia could be produced by applying traction to the floss. Two aneurysm clips were used to hold the floss. Bilateral carotid occlusion was initiated in this fashion in the experimental groups of gerbils. The surgical procedure to occlude the carotid artery was performed as previously described. 8, 18 At the end of 20 minutes, the aneurysm clips were removed and the carotid blood flow was reestablished. The control animals underwent identical surgical procedures, but their carotid arteries were not occluded.
Measurement of Leukotriene C 4
In this study, the gerbils were treated intragastrically with AA-861 in the amount of 200 mg/kg (four animals), 500 mg/kg (four animals), or 1000 mg/kg (28 animals) or with vehicle (1 ml of 7.5% gum arabic solution, 28 animals). The doses of AA-861 were dissolved in 1 ml of vehicle. One hour later, the experimental gerbils were subjected to a 20-minute occlusion followed by a reperfusion period lasting 10 minutes, 1 hour, 2 hours, or 6 hours. Twenty-four gerbils were used as a control group. With the exception of the 10-minute reperfusion group, all gerbils were reanesthetized with the anesthetic mixture at the end of each reperfusion period. The gerbils were then decapitated and their heads placed in liquid nitrogen. The brains were removed and the frontal cortex region was dissected and frozen in liquid nitrogen to measure brain levels of LTC 4 . The frozen brains from each group were homogenized in 10 ml of a mixture of 0.1% acetic acid/100% methanol. After centrifugation of the homogenates at 35,000 rpm at 4˚C for 1 hour, the supernatants were brought to a 25% methanol concentration by addition of 0.1% acetic acid. The resulting extracts were loaded onto 2-ml Sep-Pak columns that previously had been washed with 5 ml of 0.1% acetic acid in methanol and 5 ml of 0.1% acetic acid. After washing the Sep-Pak columns with 5 ml of 0.1% acetic acid and 5 ml 0.1% acetic acid containing 25% methanol, LTC 4 was eluted with 1 ml of 0.1% acetic acid containing 90% methanol. The eluates were dried under nitrogen and resuspended in enzyme-linked immunosorbent assay (ELISA) buffer. Brain levels of LTC 4 were measured according to the ELISA technique. Our preliminary studies revealed an approximately 85% rate of recovery when the leukotriene standards also underwent the same extraction procedures.
Measurement of Specific Gravity
Cerebral edema formation was assessed by measuring specific gravity by the method described earlier. 10 The animals were treated with vehicle (12 animals) or 1000 mg of AA-861 (12 animals) 1 hour before surgery. Then the animals were subjected to a 20-minute occlusion of the bilateral carotid artery and decapitated after a reperfusion period lasting 2 hours (six animals) or 6 hours (six animals). The control animals (12 animals) underwent identical surgical procedures, but their carotid arteries were not occluded. All animals were reanesthetized with the anesthetic mixture at the end of each reperfusion period. The brains from the decapitated heads were quickly removed and 2-mm 3 samples of the cortical and subcortical brain regions were dissected away. The striatum and caudoputamen were included in the subcortical brain sample. These regions were placed in a continuous density gradient column of kerosene and bromobenzene, and their specific gravity was recorded after 1 minute.
Measurement of Regional Cerebral Blood Flow
In this study, all animals were treated with vehicle or drug 1 hour before surgery. After the carotid arteries were isolated, the gerbils were placed on a stereotactic frame and a 2-mm diameter hole was made in the skull to expose the left frontal cortex. The concentric Doppler probe was placed on the exposed cortex. The temperature of the gerbils was maintained at 37˚C. The CBF was monitored with a blood perfusion monitor. After obtaining steady readings, ischemia was induced by occluding the carotid arteries in six animals treated with vehicle and six animals treated with 1000 mg/kg of AA-861. The gerbils were kept anesthetized throughout the 6-hour reperfusion period during which rCBF was measured. The anesthetic mixture (14 mg/kg ketamine and 2 mg/kg xylazine administered intraperitoneally) was supplemented hourly throughout the experiment. The flow measurements in the control animals were performed similarly but with no occlusion (six animals treated with vehicle and six animals treated with 1000 mg/kg of AA-861).
Statistical Analysis
All measurements were expressed as the mean Ϯ standard error of the mean and data were analyzed across treatment groups using one-factor analysis of variance (ANOVA). If probability was less than 0.05 for the ANOVA, group comparisons were made using the Fisher's protected least-significant difference with significance assigned to probability less than 0.05. All analyses were performed using a commercially available statistical software program.
Sources of Supplies and Equipment
In the LTC 4 measurement experiments, we used 2-ml Sep-Pak columns available from Waters & Associates, Milford, MA. The ELISA technique was accomplished using a kit obtained from Cayman Co., Ann Arbor, MI. Solvents used in the isolation of LTC 4 from the brain were obtained from Fisher Scientific Products, Pittsburgh, PA.
Cerebral blood flow was monitored with a Laserflo blood perfusion monitor, model BPM 403A, Vasamedics Inc., St. Paul, MN. All statistical analyses were performed using the StatView 512+ statistical package from Brain Power, Inc., Agoura Hills, CA, for use with the Macintosh SE computer, available from Apple Computer, Inc., Cupertino, CA.
Results

Effect of AA-861 Pretreatment on Brain Levels of Leukotriene C 4
Global cerebral ischemia-reperfusion injury in gerbils produced a significant increase in brain levels of LTC 4 ; this increase was most prominent at 2 hours of reperfusion (22 Ϯ 7 ng/g wt, p Ͻ 0.05) (Fig. 1) . Pretreatment with doses of both 500 and 1000 mg/kg AA-861 significantly inhibited brain levels of LTC 4 at 2 hours of reperfusion; however, inhibition was almost complete with the 1000-mg/kg dose (1.05 Ϯ 0.2 ng/g wt, p Ͻ 0.05).
No changes were observed in brain levels of LTC 4 in the control animals throughout the experiment (Fig. 2) . In the experimental animals an increase in brain levels of LTC 4 began at 1 hour, peaked at 2 hours, and declined between 2 and 6 hours of reperfusion. A dose of 1000 mg/kg AA-861 inhibited these increases of LTC 4 at 1, 2, and 6 hours of reperfusion (p Ͻ 0.05).
Effect of AA-861 Pretreatment on Regional Cerebral Edema
Increased cerebral edema corresponds to decreased specific gravity. A comparison of regional cerebral edema in the cortex and subcortex was made among control animals, experimental animals pretreated with vehicle, and experimental animals pretreated with 1000 mg/kg AA-861. At 6 hours of reperfusion, significant edema formation was found in the cortices of experimental animals pretreated with vehicle (p Ͻ 0.05) but not in the cortices of animals pretreated with AA-861 at a dose of 1000 mg/kg (p Ͻ 0.05) (Fig. 3) . At 6 hours of reperfusion, significant edema formation was also found in the subcortex; this edema formation was found to be decreased with AA-861 pretreatment (data not shown). At 2 hours of reperfusion, no significant edema formation was observed in the cortices or subcortices of any animals.
Effect of AA-861 Pretreatment on the Regional Cerebral Blood Flow
Regional CBF was compared among groups of control animals pretreated with vehicle, control animals pretreated with AA-861, experimental animals pretreated with vehicle, and experimental animals pretreated with AA-861. No significant differences in rCBF were found in control animals pretreated with vehicle or with AA-861. The rCBF was reduced to 10% and 7.6% of baseline by bilateral carotid occlusion in experimental animals treated with vehicle and AA-861, respectively. The rCBF was increased to 73% and 68.5% of baseline, respectively, at 1 hour after reperfusion was established. Pretreatment with AA-861 did not improve rCBF throughout the experiment (Fig. 4) .
Discussion
Several studies, including those from our laboratory, have demonstrated that brain levels of leukotrienes B 4 (LTB 4 ), C 4 , and D 4 (LTD 4 ) are increased during reperfusion after transient cerebral ischemia in gerbils and rats. 2, 9, 10, 21, 22 Although the increase in LTB 4 is modest in gerbil brains during reperfusion, previous studies from our laboratory have indicated that pretreatment with nordihydroguaiaretic acid lowered LTB 4 levels and reduced cerebral edema after transient ischemia. Although increases in LTB 4 in gerbil brains during reperfusion are modest, increases in LTC 4 and LTD 4 are marked. 9, 10, 22 This study was designed to examine the role of LTC 4 in transient ischemia-induced changes in CBF and the development of ischemic cerebral edema. Other studies have shown that a nonspecific lipoxygenase inhibitor, such as BW755C, did not decrease the development of edema after a freezing cortical injury in rats; 30 therefore, in the present study we used AA-861, a specific 5-lipoxygenase inhibitor.
The present results indicate that more than 200 mg/kg of AA-861 is required to inhibit the marked reperfusioninduced increases in LTC 4 in gerbils. The reduction was approximately 58% at 500 mg/kg and 95% at 1000 mg/kg. These observations are somewhat different from those of Minamisawa, et al., 21 who found that 200 mg/kg AA-861 reduced the increase in LTC 4 by 65% in rats. This discrepancy may arise either from differences in species or from differences in the regimen of the AA-861 administration. Minamisawa, et al., 21 administered a total of 200 mg/kg AA-861 in two doses through the same route used in this study. The present results also show that the maximum accumulation of LTC 4 occurred at approximately 2 hours of reperfusion after 20 minutes of ischemia. These observations are somewhat different from those of Moskowitz and colleagues, 22 who observed maximum increases in leukotriene at 15 minutes of reperfusion after 15 minutes of ischemia; however, their study measured total leukotrienes. These observations indicate that the maximum generation of different leukotrienes may occur at different periods of reperfusion. This possibility is also consistent with our previous observations that maximum generation of LTB 4 occurred at 10 minutes of reperfusion after 20 minutes of ischemia in gerbils. 10 In the present study, AA-861 (1000 mg/kg) administered before bilateral occlusion blocked the reperfusion-induced increases in LTC 4 between 1 and 6 hours of reperfusion.
Brain edema is an important contributing factor in the evolution of tissue damage after ischemia-reperfusion injury, causing progressive microcirculatory compression and eventual death. One approach to reducing the brain edema induced by ischemia-reperfusion injury is pharmacological therapy, which may prevent secondary metabolic events that lead to brain edema formation, such as inhibition of leukotrienes with AA-861. The present results indicate that pretreatment with AA-861 (1000 mg/kg) in gerbils subjected to 20 minutes of transient ischemia resulted in increases in specific gravity (that is, less edema formation) in both the cortical and subcortical regions. This effect was best seen after 6 hours of reperfusion. Although the specific gravity of the cortical and subcortical regions was greater in AA-861-pretreated gerbils than in vehicle-pretreated gerbils at 2 hours reperfusion, the differences did not reach statistical significance. However, at 6 hours reperfusion, the differences in the specific gravities of both the cortical and subcortical regions between the AA-861-pretreated gerbils and the vehicle-pretreated gerbils did reach statistical significance. This observation indicates that pretreatment of gerbils with AA-861 inhibited the ischemia-induced development of edema. It is possible that the use of the anesthetic agent ketamine (87 mg/kg), known as a partial N-methyl-D-aspartate receptor antagonist, might have caused reduction in brain edema; however, those reductions would probably be modest because ketamine produced only marginal attenuation of ischemia-induced neuronal cell injury and behavioral deficits at a dose of 100 mg/kg. 20 The present observation that pretreatment of gerbils with AA-861, a specific 5-lipoxygenase inhibitor, reduced the reperfusion-induced increase of brain LTC 4 and inhibited the development of edema indicates that LTC 4 is involved in the development of ischemic edema. This suggestion is also consistent with other reports that AA-861 pretreatment inhibited the development of edema following ischemia in normotensive and hypertensive rats. 19, 21 However, such a suggestion of involvement of LTC 4 in brain injury is not consistent with the observations of Unterberg and colleagues 30, 31 that BW755C, a nonspecific inhibitor of lipoxygenases, failed to attenuate edema formation after a freezing cortical injury in the rat. This discrepancy could have occurred because BW755C caused an insufficient inhibition of brain LTC 4 ; its order of inhibitory potencies from highest to lowest is cyclooxygenase, 12-lipoxygenase, 5-lipoxygenase, and 15-lipoxygenase. 13, 14, 25, 26 Therefore, in addition to LTB 4 , 10 LTC 4 is likely to be involved in the development of ischemic brain edema.
The generation of LTC 4 enhanced by 5-lipoxygenase after cerebral ischemia is probably a consequence of the accumulation of arachidonic acid during ischemia. 1, 4, 15, 17, 23, 28, 33 Arachidonic acid is metabolized by cyclooxygenase and lipoxygenase to generate the prostaglandins and leukotrienes, respectively. It is possible that the inhibition of leukotriene synthesis may result in an increased conversion of arachidonate to prostaglandins, which may effect CBF. 12, 32 Therefore, in this study we also examined the effect of pretreatment with AA-861 on CBF after ischemia. The present results indicate that pretreatment with AA-861 did not change CBF during reperfusion after ischemia. Thus, the decrease in ischemic brain edema caused by AA-861 pretreatment may primarily involve LTC 4 . The decrease in LTC 4 , induced by pretreatment with AA-861, probably caused a decrease in ischemia-induced changes in vascular permeability 3, 5, 6, 27, 29 and a subsequent FIG. 3 . Bar graph displaying specific gravities of the cortex at 2 hours and at 6 hours of reperfusion after a 20-minute occlusion. Gerbils were pretreated with either vehicle or AA-861 (1000 mg/kg) and then subjected to 20 minutes of occlusion. Gerbils in the control group were not pretreated or subjected to occlusion. Specific gravity was significantly different between the control animals and the ischemic animals pretreated with vehicle (p Ͻ 0.05); pretreatment with AA-861 increased the specific gravity of the cortex (p Ͻ 0.05). * p Ͻ 0.05 compared to control. reduction in the development of edema. 31 This suggestion is consistent with the observations of Baba and associates 3 that the intracarotid infusion of LTC 4 selectively increased blood-brain barrier permeability after focal ischemia in rats.
In conclusion, the findings reported in this study indicate that LTC 4 production during reperfusion after ischemia may be an important contributing factor to the development of brain edema because edema is attenuated by using pretreatment with AA-861 to inhibit LTC 4 production. Future studies are required to obtain the therapeutic window for AA-861.
